Is the apical soft tissue margin a better predictor of biochemical recurrence than the surgical specimen?

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 4, 2011, Pages 388-392

  Godoy, Guilherme ^a   Tareen, Basir U ^a   Lepor, Herbert ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; APICAL SOFT TISSUE MARGIN; APICAL SURGICAL MARGIN; ARTICLE; BIOCHEMICAL RECURRENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FROZEN SECTION; GLEASON SCORE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; NERVE CELL; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; RECURRENCE RISK; RECURRENT DISEASE; SOFT TISSUE; TUMOR BIOPSY; TUMOR VOLUME;

AGED; BIOPSY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959861911     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.05.009     Document Type: Article

References (19)

1. Epstein J.I., Pizov G., Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993, 71:3582-3593.
2. Karakiewicz P.I., Eastham J.A., Graefen M., et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5,831 patients. Urology 2005, 66:1245-1250.
3. Paulson D.F. Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994, 152:1826-1830.
4. Blute M.L., Bostwick D.G., Bergstralh E.J., et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 1997, 50:733-739.
5. Obek C., Sadek S., Lai S., et al. Positive surgical margins with radical retropubic prostatectomy: Anatomic site-specific pathologic analysis and impact on prognosis. Urology 1999, 54:682-688.
6. Simon M.A., Kim S., Soloway M.S. Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. J Urol 2006, 175:140-144. Discussion 144-5.
7. Sofer M., Hamilton-Nelson K.L., Civantos F., et al. Positive surgical margins after radical retropubic prostatectomy: The influence of site and number on progression. J Urol 2002, 167:2453-2456.
8. Lepor H. Radical retropubic prostatectomy. Urol Clin North Am 2001, 28:509-519. viii.
9. Examination of radical prostatectomy specimens: Therapeutic and prognostic significance 1998, 172-189. W. B. Saunders Co., Philadelphia (PA). D.G. Bostwick, C.S. Foster (Eds.).
10. Shah O., Melamed J., Lepor H. Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol 2001, 165:1943-1948. Discussion 1948-9.
11. Wieder J.A., Soloway M.S. Incidence, etiology, location, prevention, and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol 1998, 160:299-315.
12. Grossfeld G.D., Chang J.J., Broering J.M., et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: Data from the CaPSURE database. J Urol 2000, 163:1171-1177. quiz 1295.
13. Pettus J.A., Weight C.J., Thompson C.J., et al. Biochemical failure in men following radical retropubic prostatectomy: Impact of surgical margin status and location. J Urol 2004, 172:129-132.
14. Godoy G., Tareen B., Lepor H. Does location or extent of positive surgical margins (PSM) impact biochemical recurrence (BR) following open radical retropubic prostatectomy (ORRP)?. J Urol 2008, 179:198-199.
15. Cookson M.S., Aus G., Burnett A.L., et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007, 177:540-545.
16. Perlmutter M.A., Lepor H. Prostate-specific antigen doubling time is a reliable predictor of imageable metastases in men with biochemical recurrence after radical retropubic prostatectomy. Urology 2008, 71:501-505.
17. Kübler H.R., Szukala S.A., Madden J.F., et al. Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical cancer involvement. Prostate Cancer Prostatic Dis 2007, 10:72-76.
18. Dillioglugil O., Leibman B.D., Kattan M.W., Seale-Hawkins C., Wheeler T.M., Scardino P.T. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology 1997, 50:93-99.
19. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 1997, 24:395-406.